MEDvidis medical providers offer personalized treatment plans and can help you on a successful weight loss journey
So as an expert in GLP-1s, does she think Im a good candidate
Etiology Genetics COL5A1 or COL5A2 mutation in 40-50% less common mutations identified below Associated conditions Connective tissue disorder characterized by Classification Berlin Classification (1988) - revised Types I - XI exist Villefranche Classification (1998) Presentation Symptoms double-jointedness easily damaged, bruised, & stretchy skin easy scarring & poor wound healing increased joint mobility, joint popping, early arthritis chronic musculoskeletal pain (50%) Physical exam a score of 5 or more on 9-point Beighton-Horan scale defines joint hypermobility
Fibrotic fibroblasts were characterized by Fbln2 and other pathological ECM genes
Our team provides nutritional guidance as part of every program
An accompanying conference abstract and poster, presented at the 31st European Congress on Obesity in May 2024, also indicated that patients may derive cardiovascular benefit from semaglutide regardless of weight loss